$82.8 Million is the total value of SV Health Investors, LLC's 5 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $40,248,000 | -28.0% | 917,218 | -0.1% | 48.61% | +34.6% |
| BVS | Sell | BIOVENTUS, INC | $20,989,000 | -8.4% | 1,488,596 | -5.8% | 25.35% | +71.2% |
| AHCO | Sell | ADAPTHEALTH CORP | $20,694,000 | -56.4% | 1,290,978 | -33.5% | 24.99% | -18.6% |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -1,824,542 | -100.0% | -17.55% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- SVLSF VI, LLC #1
- SV Life Sciences Fund VI (GP), L.P. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSENTERIX, INC. | 27 | Q4 2020 | 24.0% |
| OCULAR THERAPEUTIX, INC. | 24 | Q2 2020 | 35.9% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 31.0% |
| DECIPHERA PHARMACEUTICALS INC | 17 | Q3 2021 | 31.0% |
| CATABASIS PHARMACEUTICALS, INC. | 15 | Q4 2018 | 18.2% |
| X4 PHARMACEUTICALS INC | 15 | Q3 2022 | 3.2% |
| BICYCLE THERAPEUTICS PLC | 14 | Q3 2022 | 65.4% |
| SUTRO BIOPHARMA INC | 14 | Q4 2021 | 19.1% |
| ENTELLUS MED INC | 12 | Q4 2017 | 64.4% |
| AVROBIO INC | 12 | Q1 2021 | 41.6% |
View SV Health Investors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
View SV Health Investors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.